Device
Central Venous Access
Central Venous Access is a medical device with 3 clinical trials. Currently 1 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Completion Rate
0%(0/1)
Active Trials
1(33%)
Terminated
1(33%)
Phase Distribution
Ph phase_4
1
33%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution1 total trials
Phase 4Post-market surveillance
1(100.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
0.0%
0 of 1 finished
Non-Completion Rate
100.0%
1 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Terminated(1)
Other(1)
Detailed Status
unknown1
Recruiting1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
0.0%
Most Advanced
Phase 4
Trials by Phase
Phase 41 (100.0%)
Trials by Status
unknown133%
recruiting133%
terminated133%
Recent Activity
1 active trials
Showing 3 of 3
recruiting
US Post-Market Surveillance Study of the Surfacer System
NCT05050799
terminatedphase_4
Oxidative Stress and Circulating Nuclear DNA (cfDNA) in Acute Kidney Injury and Continuous Renal Replacement Therapies.
NCT06646328
unknown
Siting Central Venous Catheters Precisely While Performing the Access Procedure
NCT05751395
Clinical Trials (3)
Showing 3 of 3 trials
NCT05050799
US Post-Market Surveillance Study of the Surfacer System
NCT06646328Phase 4
Oxidative Stress and Circulating Nuclear DNA (cfDNA) in Acute Kidney Injury and Continuous Renal Replacement Therapies.
NCT05751395
Siting Central Venous Catheters Precisely While Performing the Access Procedure
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3